Dr. Scott Rocklage holds the title of Managing Partner at 5AM Ventures. He has been with the company for over a decade and was promoted from Venture Partner to his current position after only one year. Dr. Rocklage has also held positions of leadership with other companies. Formerly, he was the Chief Executive Officer of EPIRUS biopharmaceuticals.
He has also served as a board member with Novira Therapeutics, where he held the title of Chairman, Ronnovia Inc., where he held the title of Director, and Cidara Therapeutics, where he currently serves as Chairman of the Board. Read more: Scott Racklage | Crunchbase and Scott Rocklage | LinkedIn
Mr. Rocklage has an impressive academic record. He is a graduate of the University of California at Berkeley, holding a Bachelor’s of Science in Chemistry. He also holds a Ph.D. in Chemistry from the prestigious Massachusetts Institute of Technology where he conducted research in the lab of Nobel Prize winner Richard R. Schrock.
The doctor has over 20 years of experience in the healthcare industry. He has entered six drug candidates into chemical trials and has been involved in the approval of three FDA new drug applications. Learn more about Dr. Scott Rocklage: http://5amventures.com/team/scott-m-rocklage-phd/
Mr. Rocklage’s desire to help his fellow man doesn’t end with his involvement in the field of healthcare, though. He and his wife have contributed at least 250,000 dollars to MIT for the renovation of the nanotechnology lab.
Dr. Rocklage is truly an exceptional person. He has devoted his life to medicine and has helped create three drugs that were approved by the FDA.
He is generous, frequently donating money to different organizations, and in a world where we are remembered for what we do, Mr. Rocklage will surely be remembered for at least one of the thirty US patents that he has been involved in the creation of.